The Assessment of Probability of Anaemia Development in Patients with HIV Infection Using Kaplan–Meier Survival Analysis

The aim of the investigation is to assess the probability of anaemia development in HIV patients with clinical and/or laboratory signs of marked immunological suppression.

Materials and Methods. There was carried out historical research of cohort (n=291) of HIV patients using Kaplan–Meier analysis of event free survival (the monitored event — anaemia). As starting point there was chosen diagnostic time of IV (a, b or and/or c phases) clinical stage of HIV infection and/or the decrease of CD4⁺ cell level below 200 in 1 mcL.

Conclusion. There has been stated high probability of anaemia development in patients with AIDS, that proves the necessity to control erythrocytes for early diagnosis and correction of anaemia.

1. Volberding P. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis 2002; 185: S110–S114.
2. Semba R.D., Martin B.K., Kempen J.H., Thorne J.E., Wu A.W. Ocular complications of AIDS research group. The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med 2005 Oct 24; 165(19): 2229–2236.
3. Levine A.M. Anemia, neutropenia, and thrombocytopenia: pathogenesis and evolving treatment options in HIV-infected patients CME. Clinical Infectious Diseases 2003; 37: S315–S322.
4. Sullivan P.S., Hanson D.L., Chu S.Y. et al. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998; 91: 301–308.
5. Sullivan P., Hanson D., Brooks J. Impact of hemoglobin of starting combination antiretroviral therapy with or whithout zidovudine in anemic HIV-infected patients. J Acquir Immune Defic Syndr 2008; 48(2): 163–168.
6. Fangman J.J., Scadden D.T. Anemia in HIV-infected adults: epidemiology, pathogenesis, and clinical management. Curr Hematol Rep 2005; 4(2): 95–102.
7. Semba R.D., Shah N., Klein R.S. et al. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus infected and uninfected women. Clin Infect Dis 2002; 34: 260–266.
8. Semba R.D., Shah N., Vlahov D. Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users. Int J STD AIDS 2002; 13(2): 119–123.
9. Kreuzer K.A., Rockstroh J.K. Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 1997; 75: 179.
10. Sloand E. Hematologic complications of HIV infection. AIDS Rev 2005; 7(4): 187–196.
11. DеMaeyer E.M. et al. Preventing and controlling iron deficiency anaemia through primary health care. A guide for health administrators and programme managers. Geneva, World Health Organization; 1989.
12. Fletcher R., Fletcher S., Vagner E. Klinicheskaya epidemio­logiya. Osnovy dokazatel’noy meditsiny [Clinical epidemio­logy. principles of evidentiary medicine]. Moscow: Media Sfera; 1998.
13. Stepanova E.Yu., Khasanova G.R., Anokhin V.A. et al. Infektsionnye bolezni 2010; 3: 9–12.
14. Volberding P.A., Levine A.M., Dieterich et al. Anemia in HIV infection: clinical impact and evidence-based mana­g­e­ment strategies. Clinical Infectious Diseases 2004; 38: 1454–1463.

Khasanova G.R., Anokhin V.А., Abrosimova А.А., Nagimova F.I. The Assessment of Probability of Anaemia Development in Patients with HIV Infection Using Kaplan–Meier Survival Analysis. Sovremennye tehnologii v medicine 2011; (4): 109